BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240130
DTEND;VALUE=DATE:20240202
DTSTAMP:20260516T004425
CREATED:20231206T112751Z
LAST-MODIFIED:20231206T112751Z
UID:38270-1706572800-1706831999@www.pharmajournalist.com
SUMMARY:2nd Next Generation Ophthalmic Drug Delivery Summit
DESCRIPTION:The 2nd Annual Next Generation Ophthalmic Drug Delivery Summit is returning to San Francisco this January to unite 90+ device engineers\, biochemists\, preclinical and clinical experts as they discuss how they are optimizing longer-lasting and less invasive delivery to the back of the eye to reduce patient concerns and burden on healthcare systems caused by frequent drug administration. \nJoin 23+ expert speakers from the likes of AbbVie\, Boehringer Ingelheim\, Bayer\, Genentech\, Janssen\, Novartis\, and Clearside Biomedical at the only industry-dedicated event focusing on overcoming key translational challenges of developing and implementing novel delivery technology as they progress their ophthalmic pipelines to the clinic. \nTo know more visit: https://ter.li/o3pq3n
URL:http://www.pharmajournalist.com/event/2nd-next-generation-ophthalmic-drug-delivery-summit/
LOCATION:The Marker San Francisco\, 501 Geary St\, San Francisco\, CA\, 94102\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240130
DTEND;VALUE=DATE:20240202
DTSTAMP:20260516T004425
CREATED:20240105T091432Z
LAST-MODIFIED:20240105T091432Z
UID:38450-1706572800-1706831999@www.pharmajournalist.com
SUMMARY:8th Microbiome Movement - Drug Development Summit Europe
DESCRIPTION:As Europe’s premiere microbiome conference tightly focused on the development of microbiome-based therapeutics\, this is your prime opportunity to expand your microbiome-based drug development capabilities and business potential as we aim to deliver clinical results and ensure therapeutic microbiome approval in Europe. \nNo matter what stage of development you’re focusing on\, this is your one-stop shop for microbiome-based drug development from early discovery to late-phase manufacturing! \nWhat’s New for 2024: \n\nHighlighting early-stage organisations and their novel technologies in our brand-new technology showcase where we welcome Centre for Genomic Regulation\, Recolony and Synflora to give quick fire presentations to showcase their work.\nDiscover our new enabling technologies track to learn more about the exciting artificial intelligence\, integrated -omics analysis and improved manufacturing capabilities among the other technologies that are accelerating microbiome-based drug development.\nStrengthen your regulatory understanding and enhance decision-making by uncovering global regulations to address updated SoHo frameworks\, explore considerations for engineered microbes and consolidate agencies interactions\n\nTo know more visit: https://ter.li/zi3xwf
URL:http://www.pharmajournalist.com/event/8th-microbiome-movement-drug-development-summit-europe/
LOCATION:Hotel Barceló Sants\, Pl. dels Països Catalans\, s/n\, 08014\, Barcelona\, 08014\, Spain
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR